ELSE-KROENER STRASSE 1, BAD HOMBURG, 2M
Interim Report of Financial Condition and Results of Operations for the Three and Nine Months Ended September 30, 2026 and 2025
Reports third quarter 2026 performance partially offsetting headwinds and narrowing full year outlook
Shervin J. Korangy appointed CEO to lead the next phase of strategic development and long-term profitable growth
Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership
Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
Material disclosure
Reports Operating Income Excluding Special Items To Be Above Market Expectations In The Second Quarter Of 2026 And Confirms Its Outlook For The Financial Year 2026
Cassie McLean Appointed As New Management Board Member For Care Delivery
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus Filed Pursuant to Rule 425
Amended Registration Statement for Securities Issued in Business-Combination Transactions
Registration Statement for Securities Issued in Business-Combination Transactions
No filings found
Amended Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Annual Report of Employee Stock Purchase
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Iran Notice